1Kloppel G, Maillet B. Pathology of chronic pancreatitis. In: Beger HG, Warshaw AL, Buchler MW, Carr-Locke DL, Neoptolemos JP, Russell C,Sarr MG, eds. The Pancreas. Oxford: Blackwell Science, 1998. 720～723.
2Kloppel G, Maillet B. Pathology of pancreatic exocrine tumors. In: Beger HG, Warshaw AL,Buchler MW, Carr-Locke DL, Neoptolemos JP,Russell C, Sarr MG, eds. The Pancreas. Oxford:Blackwell Science, 1998. 928～941.
3Ulrich CD 2nd. Growth factors, receptors, and molecular alterations in pancreatic cancer. Putting it all together. Med Clin North Am, 2000, 84:697～705, xi-xii.
4Lohr M, Maisonneuve P, Lowenfels AB. K-Ras mutations and benign pancreatic disease. Int J Pancreatol, 2000, 27: 93～103.
5Banerjee SK, Zoubine MN, Mullick M, Weston AP, Cherian R, Campbell DR. Tumor angiogenesis in chronic pancreatitis and pancreatic adenocarcinoma: impact of K-ras mutations. Pancreas,2000, 20: 248～255.
6Myung SJ, Kim MH, Kim YS, Kim HJ, Park ET,Yoo KS, Lim BC, Wan Seo D, Lee SK, Min YI,Kim JY. Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation. Gastrointest Endosc, 2000, 51: 708～713.
7eracaula R, Cleary KR, Lorenzo J, de Llorens R,Frazier ML. Human pancreatic ribonuclease 1:expression and distribution in pancreatic adenocarcinoma. Cancer, 2000, 89: 1252～1258.
8O′Reilly DA, Kingsnorth AN. Hereditary pancreatitis and mutations of the cationic trypsinogen gene. Br J Surg, 2000, 87: 708～717.
9Lowenfels AB, Maisonneuve P, Whitcomb DC.Risk factors for cancer in hereditary pancreatitis.International Hereditary Pancreatitis Study Group. Med Clin North Am, 2000, 84: 565～573.
